retatrutide effects clinical trial Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v Retatrutide Dosage Chart: Doses, Units

Coverage and reimbursement, if any, depend on your individual plan

Response rates were strong across the board: 91.7% of participants on the 12mg dose achieved at least 10% body weight reduction

Some of the common ones are: Nausea Headache Stomach pain Heartburn Dizziness Mood changes Experts say its important for people prescribed GLP-1 medications to recognize that the drugs are part of a long-term treatment plan that involves lifestyle factors such as a balanced, healthy diet and regular aerobic and strength exercise

Youre ecstaticyouve met your digits and you think, Well, I dont need to take this medication anymore. But what happens if you stop taking it